CDT Equity Inc. (CDT) vs Decoy Therapeutics Inc. (DCOY)

A side-by-side comparison of CDT Equity Inc. and Decoy Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CDT vs DCOY

growth of $100 · dividends reinvested · last 3y
CDT -100.0% (-99.8%/yr)DCOY -99.7% (-86.0%/yr)DCOY compounded faster over this window
Log scale — wide-divergence pair
0000001101001kStart $100202420252026$0$0
CDT DCOY

CDT vs DCOY: by the numbers

  • •DCOY is the larger company ($888387 vs $707297 market cap).
  • •CDT is profitable (6.30% net margin) while DCOY runs a net loss (0.00%).

Metrics side by side

Valuation

MetricCDTDCOY
P/S ratio0.00N/A
P/B ratio0.000.21
EV / EBITDA4.13N/A

Profitability

MetricCDTDCOY
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin6.30%0.00%
ROE6.58%-334.41%
ROIC4.47%-343.55%

Growth (annualized)

MetricCDTDCOY
Total return CAGR (5Y)N/A-86.39%

Frequently asked

Is CDT or DCOY more profitable?
CDT runs the higher net margin — CDT at 6.30% versus DCOY at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.